WO1999059626A1 - Compositions and method for immunizing poultry - Google Patents
Compositions and method for immunizing poultry Download PDFInfo
- Publication number
- WO1999059626A1 WO1999059626A1 PCT/US1999/010650 US9910650W WO9959626A1 WO 1999059626 A1 WO1999059626 A1 WO 1999059626A1 US 9910650 W US9910650 W US 9910650W WO 9959626 A1 WO9959626 A1 WO 9959626A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- bacterin
- vaccine composition
- production
- media
- cultures
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 63
- 238000000034 method Methods 0.000 title claims abstract description 50
- 244000144977 poultry Species 0.000 title claims abstract description 21
- 230000003053 immunization Effects 0.000 title claims abstract description 15
- 229960005486 vaccine Drugs 0.000 claims abstract description 68
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 230000005540 biological transmission Effects 0.000 claims description 28
- 241000588724 Escherichia coli Species 0.000 claims description 21
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 claims description 20
- 239000003755 preservative agent Substances 0.000 claims description 18
- 241001135620 Ornithobacterium rhinotracheale Species 0.000 claims description 16
- 230000002335 preservative effect Effects 0.000 claims description 16
- 241000588851 Bordetella avium Species 0.000 claims description 13
- 241001478212 Riemerella anatipestifer Species 0.000 claims description 12
- 239000003242 anti bacterial agent Substances 0.000 claims description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 10
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims description 10
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims description 10
- 229960002216 methylparaben Drugs 0.000 claims description 10
- LXCFILQKKLGQFO-UHFFFAOYSA-N p-hydroxybenzoic acid methyl ester Natural products COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims description 10
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 claims description 10
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 claims description 10
- 229960003415 propylparaben Drugs 0.000 claims description 10
- 229930182555 Penicillin Natural products 0.000 claims description 9
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 8
- 229940049954 penicillin Drugs 0.000 claims description 8
- 238000002649 immunization Methods 0.000 claims description 7
- 230000003115 biocidal effect Effects 0.000 claims description 6
- 241000606856 Pasteurella multocida Species 0.000 claims description 5
- 229940051027 pasteurella multocida Drugs 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 230000035622 drinking Effects 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 abstract description 9
- 238000004519 manufacturing process Methods 0.000 description 93
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 56
- 239000007789 gas Substances 0.000 description 41
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 39
- 241000271566 Aves Species 0.000 description 35
- 238000011218 seed culture Methods 0.000 description 33
- 238000003306 harvesting Methods 0.000 description 32
- 244000144992 flock Species 0.000 description 27
- 238000011081 inoculation Methods 0.000 description 25
- 208000015181 infectious disease Diseases 0.000 description 24
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 24
- 239000012467 final product Substances 0.000 description 23
- 102100023961 ADP-ribosylation factor-like protein 2-binding protein Human genes 0.000 description 20
- 101000757692 Homo sapiens ADP-ribosylation factor-like protein 2-binding protein Proteins 0.000 description 20
- 101000934823 Homo sapiens Barttin Proteins 0.000 description 20
- 239000000463 material Substances 0.000 description 18
- 241000286209 Phasianidae Species 0.000 description 16
- 230000002779 inactivation Effects 0.000 description 16
- 238000012809 post-inoculation Methods 0.000 description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 239000000427 antigen Substances 0.000 description 14
- 108091007433 antigens Proteins 0.000 description 14
- 102000036639 antigens Human genes 0.000 description 14
- 235000013594 poultry meat Nutrition 0.000 description 14
- 201000010099 disease Diseases 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 239000003651 drinking water Substances 0.000 description 13
- 235000020188 drinking water Nutrition 0.000 description 13
- 239000001963 growth medium Substances 0.000 description 12
- 238000003860 storage Methods 0.000 description 12
- 229960005322 streptomycin Drugs 0.000 description 12
- 239000001974 tryptic soy broth Substances 0.000 description 12
- 108010050327 trypticase-soy broth Proteins 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- 239000013587 production medium Substances 0.000 description 11
- 239000000725 suspension Substances 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 239000006185 dispersion Substances 0.000 description 10
- 239000011521 glass Substances 0.000 description 10
- 238000011534 incubation Methods 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 239000006161 blood agar Substances 0.000 description 9
- 208000023504 respiratory system disease Diseases 0.000 description 9
- 230000001954 sterilising effect Effects 0.000 description 9
- 238000004659 sterilization and disinfection Methods 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 241000272517 Anseriformes Species 0.000 description 7
- 229940088710 antibiotic agent Drugs 0.000 description 7
- 238000005096 rolling process Methods 0.000 description 7
- 239000002518 antifoaming agent Substances 0.000 description 6
- 230000000890 antigenic effect Effects 0.000 description 6
- 239000000975 dye Substances 0.000 description 6
- 230000001747 exhibiting effect Effects 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- 238000005273 aeration Methods 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000012595 freezing medium Substances 0.000 description 5
- 230000036512 infertility Effects 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 235000020183 skimmed milk Nutrition 0.000 description 5
- 239000003381 stabilizer Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 239000004575 stone Substances 0.000 description 5
- 108010038854 colibacterin Proteins 0.000 description 4
- 230000009885 systemic effect Effects 0.000 description 4
- 239000003053 toxin Substances 0.000 description 4
- 231100000765 toxin Toxicity 0.000 description 4
- 108700012359 toxins Proteins 0.000 description 4
- 241000711404 Avian avulavirus 1 Species 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 241000588807 Bordetella Species 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 3
- 239000006154 MacConkey agar Substances 0.000 description 3
- 241000711902 Pneumovirus Species 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 229940031551 inactivated vaccine Drugs 0.000 description 3
- 238000005057 refrigeration Methods 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 210000003437 trachea Anatomy 0.000 description 3
- 208000006029 Cardiomegaly Diseases 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 241000606860 Pasteurella Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000002306 biochemical method Methods 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 2
- 229940124452 immunizing agent Drugs 0.000 description 2
- 230000002906 microbiologic effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000016379 mucosal immune response Effects 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000020192 tolerance induction in gut-associated lymphoid tissue Effects 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241001519465 Avian metapneumovirus Species 0.000 description 1
- 208000018150 Bordetella infection Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 241001135630 Ornithobacterium Species 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010038687 Respiratory distress Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229940126575 aminoglycoside Drugs 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 208000015114 central nervous system disease Diseases 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229940001442 combination vaccine Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- -1 etc.) Natural products 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 230000003090 exacerbative effect Effects 0.000 description 1
- 239000000989 food dye Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000012768 mass vaccination Methods 0.000 description 1
- 238000012009 microbiological test Methods 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 229960005030 other vaccine in atc Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 150000002960 penicillins Chemical class 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 231100000033 toxigenic Toxicity 0.000 description 1
- 230000001551 toxigenic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0258—Escherichia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99924234A EP1076567A4 (en) | 1998-05-15 | 1999-05-14 | Compositions and method for immunizing poultry |
IL13953899A IL139538A0 (en) | 1998-05-15 | 1999-05-14 | Compositions and method for immunizing poultry |
CA002332246A CA2332246A1 (en) | 1998-05-15 | 1999-05-14 | Compositions and method for immunizing poultry |
BR9910438-5A BR9910438A (en) | 1998-05-15 | 1999-05-14 | Compositions and processes for poultry immunization |
AU40786/99A AU4078699A (en) | 1998-05-15 | 1999-05-14 | Compositions and method for immunizing poultry |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8563498P | 1998-05-15 | 1998-05-15 | |
US60/085,634 | 1998-05-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1999059626A1 true WO1999059626A1 (en) | 1999-11-25 |
Family
ID=22192933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/010650 WO1999059626A1 (en) | 1998-05-15 | 1999-05-14 | Compositions and method for immunizing poultry |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1076567A4 (en) |
AU (1) | AU4078699A (en) |
BR (1) | BR9910438A (en) |
CA (1) | CA2332246A1 (en) |
IL (1) | IL139538A0 (en) |
WO (1) | WO1999059626A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002002139A2 (en) * | 2000-06-30 | 2002-01-10 | Wyeth | Methods and composition for oral vaccination |
CN102323428A (en) * | 2011-08-17 | 2012-01-18 | 湖北省农业科学院畜牧兽医研究所 | Riemerella anatipestifer antibody indirect ELISA method detection kit and application thereof |
CN108486012A (en) * | 2017-09-04 | 2018-09-04 | 广东省农业科学院动物卫生研究所 | Duck infectious serositis live vaccine and preparation method thereof |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3855408A (en) * | 1973-07-16 | 1974-12-17 | Univ Minnesota | Poultry vaccine |
US4423035A (en) * | 1981-08-10 | 1983-12-27 | Schering Corporation | Method for preventing injection site abscess |
US4472378A (en) * | 1982-12-30 | 1984-09-18 | Shuster Boris J | Live vaccine for the prevention of salmonellosis in water fowl, a process for making and applying the same |
US4746613A (en) * | 1984-03-02 | 1988-05-24 | Wichmann Robert W | Poultry diseases bacterin preparation |
EP0413378A1 (en) * | 1989-08-18 | 1991-02-20 | Akzo Nobel N.V. | Escherichia coli vaccine |
US5000951A (en) * | 1987-03-09 | 1991-03-19 | Diamond Scientific Company | Multivalent canine distemper virus vaccine |
US5536496A (en) * | 1990-06-13 | 1996-07-16 | Pfizer Inc. | Pasteurella multocida toxoid vaccines |
US5576003A (en) * | 1992-10-14 | 1996-11-19 | Akzo Nobel N.V. | Ornithobacterium rhinotracheale vaccine and method of immunization |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU826584A1 (en) * | 1979-10-29 | 1982-11-07 | Всесоюзный государственный научно-контрольный институт ветеринарных препаратов | Vaccine against newcastle fowl disease, process for preparing the same and method for prophylaxis of newcastle fowl diease |
-
1999
- 1999-05-14 BR BR9910438-5A patent/BR9910438A/en not_active Application Discontinuation
- 1999-05-14 EP EP99924234A patent/EP1076567A4/en not_active Withdrawn
- 1999-05-14 IL IL13953899A patent/IL139538A0/en unknown
- 1999-05-14 AU AU40786/99A patent/AU4078699A/en not_active Abandoned
- 1999-05-14 CA CA002332246A patent/CA2332246A1/en not_active Abandoned
- 1999-05-14 WO PCT/US1999/010650 patent/WO1999059626A1/en not_active Application Discontinuation
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3855408A (en) * | 1973-07-16 | 1974-12-17 | Univ Minnesota | Poultry vaccine |
US4423035A (en) * | 1981-08-10 | 1983-12-27 | Schering Corporation | Method for preventing injection site abscess |
US4472378A (en) * | 1982-12-30 | 1984-09-18 | Shuster Boris J | Live vaccine for the prevention of salmonellosis in water fowl, a process for making and applying the same |
US4746613A (en) * | 1984-03-02 | 1988-05-24 | Wichmann Robert W | Poultry diseases bacterin preparation |
US5000951A (en) * | 1987-03-09 | 1991-03-19 | Diamond Scientific Company | Multivalent canine distemper virus vaccine |
EP0413378A1 (en) * | 1989-08-18 | 1991-02-20 | Akzo Nobel N.V. | Escherichia coli vaccine |
US5536496A (en) * | 1990-06-13 | 1996-07-16 | Pfizer Inc. | Pasteurella multocida toxoid vaccines |
US5576003A (en) * | 1992-10-14 | 1996-11-19 | Akzo Nobel N.V. | Ornithobacterium rhinotracheale vaccine and method of immunization |
Non-Patent Citations (1)
Title |
---|
See also references of EP1076567A4 * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002002139A2 (en) * | 2000-06-30 | 2002-01-10 | Wyeth | Methods and composition for oral vaccination |
WO2002002139A3 (en) * | 2000-06-30 | 2002-07-04 | Wyeth Corp | Methods and composition for oral vaccination |
AU2001270135B2 (en) * | 2000-06-30 | 2005-05-26 | Wyeth | Methods and composition for oral vaccination |
CN100457179C (en) * | 2000-06-30 | 2009-02-04 | 惠氏公司 | Method and composition for oral vaccination |
CN102323428A (en) * | 2011-08-17 | 2012-01-18 | 湖北省农业科学院畜牧兽医研究所 | Riemerella anatipestifer antibody indirect ELISA method detection kit and application thereof |
CN108486012A (en) * | 2017-09-04 | 2018-09-04 | 广东省农业科学院动物卫生研究所 | Duck infectious serositis live vaccine and preparation method thereof |
CN108486012B (en) * | 2017-09-04 | 2021-06-22 | 广东省农业科学院动物卫生研究所 | Duck infectious serositis live vaccine and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
BR9910438A (en) | 2001-01-02 |
EP1076567A1 (en) | 2001-02-21 |
CA2332246A1 (en) | 1999-11-25 |
EP1076567A4 (en) | 2001-12-12 |
IL139538A0 (en) | 2004-02-08 |
AU4078699A (en) | 1999-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001270135B2 (en) | Methods and composition for oral vaccination | |
CN101524532B (en) | Single dose of a mycoplasma hyopneumoniae vaccine | |
AU2001270135A1 (en) | Methods and composition for oral vaccination | |
US10143714B2 (en) | In ovo delivery of probiotic cultures | |
CN102058880B (en) | Method for producing trivalent inactivated vaccines for porcine infectious pleuropneumonia | |
JP5334029B2 (en) | Avian Escherichia coli vaccine for protection against colibacillosis | |
CN110882384B (en) | Oral vaccine of pig epidemic diarrhea-pig clostridium enteritis bigeminal subunit and preparation method thereof | |
RU2428202C1 (en) | Associated vaccine against anaerobic enterotoxemia and colibacillosis diarrhea in calves | |
WO1999059626A1 (en) | Compositions and method for immunizing poultry | |
KR100372278B1 (en) | Mixture vaccine for pig respiratory organ | |
US6517844B1 (en) | Compositions and method for immunizing polutry | |
US20110014237A1 (en) | Vaccine for Protection Against Haemophilus Parasuis Serotype 4 in Piglets | |
RU2761966C2 (en) | Oral vaccine against respiratory disease of ruminants containing polyvinylpyrrolidone | |
US4002736A (en) | Porcine bacterin | |
RU2761379C1 (en) | Polyvalent inactivated vaccine against swine streptococcosis, method for its production and use | |
EP0012718B1 (en) | Intra-respiratory vaccine, modified bacteria strain used in it, vaccine dose form and process for preparing it | |
RU2763991C1 (en) | Vaccine against infectious atrophic rhinitis and pasterellosis in pigs inactivated, method for its preparation | |
RU2043771C1 (en) | Vaccine against escherichiosis in animals | |
WO2021021778A1 (en) | A composition for mucosal administration to avians | |
RU2163142C2 (en) | Inactivated emulsin-vaccine against salmonellosis in piglets | |
CN115381932A (en) | Trivalent inactivated vaccine for avian colibacillosis and preparation method thereof | |
KR20210045901A (en) | A vaccine composition comprising Lactobacillus Plantarum and Fowl Adenovirus | |
AU2005203441A1 (en) | Methods and composition for oral vaccination | |
Bourhy et al. | 5.1 Louis Pasteur: A Brief Biography | |
GB2274852A (en) | Competitive exclusion preparation comprising an anaerobic culture of microflora from the caecum of a bird |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CU CZ CZ DE DE DK DK EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 40786/99 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 139538 Country of ref document: IL |
|
ENP | Entry into the national phase |
Ref document number: 2332246 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999924234 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999924234 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999924234 Country of ref document: EP |